Tower Research Capital (TRC)’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.5K Buy
9,166
+1,064
+13% +$3.31K ﹤0.01% 3450
2025
Q1
$27.4K Buy
8,102
+2,719
+51% +$9.19K ﹤0.01% 2684
2024
Q4
$30.5K Buy
5,383
+3,077
+133% +$17.4K ﹤0.01% 2891
2024
Q3
$13.5K Sell
2,306
-8,647
-79% -$50.6K ﹤0.01% 3516
2024
Q2
$86.6K Buy
10,953
+10,534
+2,514% +$83.3K ﹤0.01% 2679
2024
Q1
$3.9K Sell
419
-5,980
-93% -$55.7K ﹤0.01% 4772
2023
Q4
$54K Buy
6,399
+4,809
+302% +$40.6K ﹤0.01% 3084
2023
Q3
$12.3K Sell
1,590
-335
-17% -$2.6K ﹤0.01% 3903
2023
Q2
$22K Buy
1,925
+1,177
+157% +$13.5K ﹤0.01% 3280
2023
Q1
$6K Sell
748
-5,748
-88% -$46.1K ﹤0.01% 4888
2022
Q4
$40K Buy
+6,496
New +$40K ﹤0.01% 2520
2022
Q2
Sell
-19,339
Closed -$147K 6564
2022
Q1
$147K Sell
19,339
-23,627
-55% -$180K ﹤0.01% 1958
2021
Q4
$116K Buy
42,966
+30,238
+238% +$81.6K ﹤0.01% 2142
2021
Q3
$34K Buy
12,728
+6,980
+121% +$18.6K ﹤0.01% 3272
2021
Q2
$24K Buy
5,748
+1,132
+25% +$4.73K ﹤0.01% 3736
2021
Q1
$21K Buy
4,616
+3,267
+242% +$14.9K ﹤0.01% 3853
2020
Q4
$10K Sell
1,349
-7,673
-85% -$56.9K ﹤0.01% 4328
2020
Q3
$96K Buy
9,022
+4,871
+117% +$51.8K ﹤0.01% 3176
2020
Q2
$52K Buy
+4,151
New +$52K ﹤0.01% 3016
2019
Q4
Sell
-539
Closed -$9K 4444
2019
Q3
$9K Buy
+539
New +$9K ﹤0.01% 3018
2019
Q2
Sell
-7,775
Closed -$149K 4364
2019
Q1
$149K Buy
7,775
+6,225
+402% +$119K 0.01% 1254
2018
Q4
$15K Buy
+1,550
New +$15K ﹤0.01% 2178
2018
Q3
Sell
-151
Closed -$3K 4291
2018
Q2
$3K Buy
+151
New +$3K ﹤0.01% 3262
2018
Q1
Sell
-534
Closed -$9K 3945
2017
Q4
$9K Sell
534
-1,809
-77% -$30.5K ﹤0.01% 2631
2017
Q3
$48K Buy
+2,343
New +$48K ﹤0.01% 2023
2016
Q4
Sell
-1,084
Closed -$13K 4467
2016
Q3
$13K Buy
+1,084
New +$13K ﹤0.01% 1893
2016
Q2
Sell
-3,450
Closed -$30K 5045
2016
Q1
$30K Buy
3,450
+2,840
+466% +$24.7K ﹤0.01% 1073
2015
Q4
$13K Buy
+610
New +$13K ﹤0.01% 1817